Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma. - Kankeu Fonkoua LA; Chakrabarti S; Sonbol MB; Kasi PM; Starr JS; Liu AJ; Nevala WK; Maus RL; Bois MC; Pitot HC; Chandrasekharan C; Ross HJ; et al. (International journal of cancer, 2021)